Clinical Trial Update: Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hepatic artery infusion chemotherapy with donafenib in hepatocellular carcinoma after surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Neoplasms
• Hepatocellular Carcinoma
• Liver Neoplasms

Drugs mentioned

• Donafenib (donafenib)
• FLUOROURACIL (Fluorouracil)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Carcinoma, Carcinoma, Hepatocellular | Phase 2 | Status: UNKNOWN